Insider · CIK 0001553354

Hager Alicia J.

Reports to the SEC for 2 companies · REDWOOD CITY, CA

sec.gov

Transactions

Companies

Filings

CIK

0001553354

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-01-15	NKTXNkarta, Inc.S Sale	Chief Legal Officer	SSale	−9,584 sh	$2.20	−$21.1K	146,735
2025-01-03	NKTXNkarta, Inc.A Award	Chief Legal Officer	AAward	+52.5K sh	—	—	156,319
2025-01-03	NKTXNkarta, Inc. · Stock Option (right to buy)A Award	Chief Legal Officer	AAward	+105K sh	—	—	105,000
2024-07-16	NKTXNkarta, Inc.S Sale	Chief Legal Officer	SSale	−3,396 sh	$8.00	−$27.2K	103,819
2024-06-18	NKTXNkarta, Inc.S Sale	Chief Legal Officer	SSale	−727 sh	$5.60	−$4,071.2	107,215
2024-01-16	NKTXNkarta, Inc.S Sale	Chief Legal Officer	SSale	−4,554 sh	$8.74	−$39.8K	107,942
2024-01-04	NKTXNkarta, Inc.A Award	Chief Legal Officer	AAward	+56K sh	—	—	112,496
2024-01-04	NKTXNkarta, Inc. · Stock Option (right to buy)A Award	Chief Legal Officer	AAward	+113K sh	—	—	112,500
2023-06-20	NKTXNkarta, Inc.S Sale	Chief Legal Officer	SSale	−701 sh	$4.85	−$3,399.85	56,496
2023-01-17	NKTXNkarta, Inc.S Sale	Chief Legal Officer	SSale	−1,103 sh	$5.49	−$6,055.47	57,197
2023-01-13	NKTXNkarta, Inc.A Award	Chief Legal Officer	AAward	+37.5K sh	—	—	58,300
2023-01-13	NKTXNkarta, Inc. · Stock Option (right to buy)A Award	Chief Legal Officer	AAward	+75K sh	—	—	75,000
2022-06-17	NKTXNkarta, Inc. · Stock Option (right to buy)A Award	Chief Legal Officer	AAward	+50.5K sh	—	—	50,500
2022-06-17	NKTXNkarta, Inc.A Award	Chief Legal Officer	AAward	+8,000 sh	—	—	20,800
2022-01-14	NKTXNkarta, Inc. · Stock Option (right to buy)A Award	Chief Legal Officer	AAward	+76.8K sh	—	—	76,800
2022-01-14	NKTXNkarta, Inc.A Award	Chief Legal Officer	AAward	+12.8K sh	—	—	12,800
2022-01-14	NKTXNkarta, Inc. · Stock Option (right to buy)A Award	Chief Legal Officer	AAward	+20K sh	—	—	20,000
2021-01-08	NKTXNkarta, Inc. · Stock Option (right to buy)A Award	Chief Legal Officer	AAward	+13.1K sh	—	—	13,125
2020-10-26	NKTXNkarta, Inc. · Stock Option (right to buy)A Award	Chief Legal Officer	AAward	+150K sh	—	—	150,000
2019-04-23	OncoMed Pharmaceuticals IncU Disposition from Tender	SVP and General Counsel	UDisposition from Tender	−39.5K sh	—	—	0
2018-10-10	OncoMed Pharmaceuticals IncS Sale	SVP and General Counsel	SSale	−1,156 sh	$2.02	−$2,335.12	51,754
2018-10-09	OncoMed Pharmaceuticals IncS Sale	SVP and General Counsel	SSale	−1,686 sh	$2.13	−$3,589.157	52,910
2018-04-24	OncoMed Pharmaceuticals IncS Sale	SVP and General Counsel	SSale	−4,051 sh	$2.68	−$10.8K	54,596
2017-10-10	OncoMed Pharmaceuticals IncS Sale	SVP and General Counsel	SSale	−1,202 sh	$4.24	−$5,098.644	58,647
2017-10-10	OncoMed Pharmaceuticals IncS Sale	SVP and General Counsel	SSale	−46 sh	$4.26	−$195.978	59,849
2017-10-07	OncoMed Pharmaceuticals IncA Award	SVP and General Counsel	AAward	+18.3K sh	—	—	59,895
2017-10-07	OncoMed Pharmaceuticals IncStock Option (Right to Buy)A Award	SVP and General Counsel	AAward	+36.7K sh	—	—	36,666
2017-04-23	OncoMed Pharmaceuticals IncStock Option (Right to Buy)A Award	SVP and General Counsel	AAward	+60K sh	—	—	60,000
2017-04-23	OncoMed Pharmaceuticals IncA Award	SVP and General Counsel	AAward	+20K sh	—	—	41,561
2017-04-04	OncoMed Pharmaceuticals IncS Sale	SVP and General Counsel	SSale	−32 sh	$8.87	−$283.978	25,845
2017-04-04	OncoMed Pharmaceuticals IncS Sale	SVP and General Counsel	SSale	−4,284 sh	$9.06	−$38.8K	21,561
2017-03-15	OncoMed Pharmaceuticals IncS Sale	SVP and General Counsel	SSale	−6,652 sh	$10.00	−$66.5K	25,877
2017-03-15	OncoMed Pharmaceuticals IncStock Option (Right to Buy)M Exercise/Conversion	SVP and General Counsel	MExercise/Conversion	−6,652 sh	—	—	0
2017-03-15	OncoMed Pharmaceuticals IncM Exercise/Conversion	SVP and General Counsel	MExercise/Conversion	+6,652 sh	$3.42	+$22.7K	32,529
2017-01-03	OncoMed Pharmaceuticals IncStock Option (Right to Buy)A Award	SVP and General Counsel	AAward	+55K sh	—	—	55,000
2016-10-09	OncoMed Pharmaceuticals IncA Award	SVP and General Counsel	AAward	+12.5K sh	—	—	25,877
2016-01-07	OncoMed Pharmaceuticals IncS Sale	SVP and General Counsel	SSale	−1 sh	$21.33	−$21.33	13,377
2016-01-06	OncoMed Pharmaceuticals IncS Sale	SVP and General Counsel	SSale	−52 sh	$21.54	−$1,120.21	13,378
2016-01-06	OncoMed Pharmaceuticals IncS Sale	SVP and General Counsel	SSale	−1,570 sh	$22.30	−$35K	13,430
2015-12-27	OncoMed Pharmaceuticals IncStock Option (Right to Buy)A Award	SVP and General Counsel	AAward	+40K sh	—	—	40,000
2015-11-27	OncoMed Pharmaceuticals IncS Sale	SVP and General Counsel	SSale	−1,800 sh	$23.14	−$41.7K	15,000
2015-11-27	OncoMed Pharmaceuticals IncM Exercise/Conversion	SVP and General Counsel	MExercise/Conversion	+1,800 sh	$3.42	+$6,156	16,800
2015-11-27	OncoMed Pharmaceuticals IncStock Option (Right to Buy)M Exercise/Conversion	SVP and General Counsel	MExercise/Conversion	−1,800 sh	—	—	6,652
2015-10-27	OncoMed Pharmaceuticals IncStock Option (Right to Buy)M Exercise/Conversion	SVP and General Counsel	MExercise/Conversion	−5,400 sh	—	—	8,452
2015-10-27	OncoMed Pharmaceuticals IncS Sale	SVP and General Counsel	SSale	−5,400 sh	$21.00	−$113K	15,000
2015-10-27	OncoMed Pharmaceuticals IncM Exercise/Conversion	SVP and General Counsel	MExercise/Conversion	+5,400 sh	$3.42	+$18.5K	20,400
2015-07-28	OncoMed Pharmaceuticals IncM Exercise/Conversion	SVP and General Counsel	MExercise/Conversion	+1,800 sh	$3.42	+$6,156	16,800
2015-07-28	OncoMed Pharmaceuticals IncS Sale	SVP and General Counsel	SSale	−1,800 sh	$21.00	−$37.8K	15,000
2015-07-28	OncoMed Pharmaceuticals IncStock Option (Right to Buy)M Exercise/Conversion	SVP and General Counsel	MExercise/Conversion	−1,800 sh	—	—	13,852
2015-06-29	OncoMed Pharmaceuticals IncStock Option (Right to Buy)M Exercise/Conversion	SVP and General Counsel	MExercise/Conversion	−1,800 sh	—	—	15,652

Recent filings

Accepted (ET)
Jan 174
Hager Alicia J.0000950170-25-006823
SEC(opens sec.gov)
Jan 74
Hager Alicia J.0000950170-25-002832
SEC(opens sec.gov)
Jul 184
Hager Alicia J.0000950170-24-084588
SEC(opens sec.gov)
Jun 204
Hager Alicia J.0000950170-24-075728
SEC(opens sec.gov)
Jan 184
Hager Alicia J.0000950170-24-005425
SEC(opens sec.gov)
Jan 84
Hager Alicia J.0001209191-24-001158
SEC(opens sec.gov)
Jun 224
Hager Alicia J.0001209191-23-039057
SEC(opens sec.gov)
Jan 184
Hager Alicia J.0001209191-23-003852
SEC(opens sec.gov)
Jun 214
Hager Alicia J.0001209191-22-038528
SEC(opens sec.gov)
Jan 194
Hager Alicia J.0001209191-22-003755
SEC(opens sec.gov)
Jan 124
Hager Alicia J.0000899243-21-001463
SEC(opens sec.gov)
Oct 284
Hager Alicia J.0000899243-20-029553
SEC(opens sec.gov)
Apr 234
Hager Alicia J.0000899243-19-010990
SEC(opens sec.gov)

Companies

Address

C/O ONCOMED PHARMACEUTICALS, INC. 800 CHESAPEAKE DRIVE

REDWOOD CITY, CA, 94063